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Abstract: Components of protein phosphorylation signalling systems have been discovered in mitochondria and it has 
been proposed that these molecules modulate processes including oxidative phosphorylation, apoptosis and steroidogene-
sis.  
We used electrophoresis and Western blots probed with specific antibodies to protein kinase A  catalytic subunit (PKAα 
Cat) and A kinase anchoring protein of approximately 79 kDa molecular weight (AKAP79) to demonstrate the presence 
of these two proteins in human placental mitochondria. Heavy mitochondria characteristic of cytotrophoblast were sepa-
rated from light mitochondria characteristic of syncytiotrophoblast by centrifugation. PKAα Cat and AKAP79 were pre-
sent in both heavy and light mitochondria with no significant difference in concentration. Sucrose density gradient separa-
tion of submitochondrial fractions indicated PKAα Cat is located predominantly in the outer membrane whereas AKAP79 
is present mainly in the contact site fractions.  
These data indicate that PKAα Cat is present in the cytoplasm, nucleus and mitochondria of placental cells. AKAP79 is 
also present in human placental mitochondria but there may be anchoring proteins other than AKAP79 responsible for fix-
ing PKA to the outer membrane. PKA may play roles in mitochondrial protein phosphorylation systems in both cytotro-
phoblast and syncytiotrophoblast. 
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INTRODUCTION 
  It has been known for some time that protein phosphory-
lation by protein kinases is an important component of cellu-
lar signalling systems that are located in the plasma mem-
brane, nucleus and cytoplasm [1]. Relatively little is known, 
however, about cellular signalling from these regions to the 
mitochondria but several groups have explored the hypothe-
sis that protein phosphorylation plays an important role in 
the signalling systems that operate in the mitochondrion [2-
6]. In many tissues it is known that protein kinases phos-
phorylate and activate key proteins such as receptors, en-
zymes and ion channels and these can in turn then affect 
cellular functions such as metabolism, differentiation and 
endocrine functions [1, 2]. One of the most common protein 
kinases, cAMP-dependent protein kinase (PKA) can migrate 
to many areas of the cell and is often held in a precise cellu-
lar location by A kinase anchoring proteins (AKAPs) [7]. 
There are several forms of AKAP (often differentiated by a 
suffix corresponding to their molecular weight) that have 
been found in tissues and species other than placenta and 
human. The only form of AKAP found in human reproduc-
tive tissue prior to this investigation was AKAP79 which, 
was shown to be present in the cytoplasm of human 
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myometrium and is thought to anchor PKA to the myo-
metrial plasma membrane [8]. 
  PKA is activated when cAMP binds to the two regulatory 
(Reg) subunits, which disengage to release consequently 
active catalytic (Cat) subunits. There are three known iso-
forms of the Cat subunit; these are Cat,  Cat, and 
Catand are four known isoforms of the Reg subunit, these 
are type IReg, IReg, IIReg and II Reg [9]. PKA is 
only active when cAMP binds to the Reg subunits, causing 
Cat subunits to dissociate as free and active units [10] and 
migrate to different areas of the cell [11]. PKA components 
have been found in the mitochondria of some species and 
tissues [2], for example, in the mouse oocyte [12].  
  PKA enzyme activity has been found in the mitochondria 
of human placenta and the enzyme appears to contribute to 
the phosphorylation of a 20 kDa mitochondrial protein 
(MP20). Modulation of protein phosphorylation in the mito-
chondria may regulate the physiological processes that mito-
chondria are involved in, in different tissues such as apop-
tosis, ATP generation and steroid hormone synthesis [2, 13]. 
The finding of PKA enzyme activity in placental mitochon-
dria led to the speculation that PKA is secured in this loca-
tion by an AKAP [2]. Furthermore, it has been suggested 
that this placental and mitochondrial PKA may phosphory-
late and activate important modulators of placental physiol-
ogy such as the Steroidogenic Acute Regulatory protein 
(StAR) [2, 14]. Such an activation of StAR may be able to 
increase StAR’s regulation of cholesterol transport from the 24    The Open Biochemistry Journal, 2012, Volume 6  Ma and Thomson 
outer mitochondrial membrane to the inner membrane where 
it is converted into progesterone in the first and rate-limiting 
step in steroidogenesis [15-17].  
  A vital developmental event for the placenta is the differ-
entiation of trophoblast cells into cytotrophoblast and 
syncytiotrophoblast [18]. The placental steroid hormones 
that are vital for pregnancy to progress successfully to term 
are produced in the syncytiotrophoblast [19]. Mitochondria 
from the syncytiotrophoblast are lighter than those of the 
cytotrophoblast and therefore centrifugation can be used to 
separate the organelles from either cell type of cell [20, 21]. 
In this study we used specific antibodies to investigate the 
possibility that PKACat and AKAP79 are present in vari-
ous locations in the human placenta including mitochondria 
from both cytotrophoblast and syncytiotrophoblast. 
MATERIALS & METHODS 
Isolation of Mitochondria from Human Placenta 
  Human term placentae were collected from the Royal 
Prince Alfred Hospital, Sydney, and perfused in chilled 
phosphate saline buffer (PBS) to remove blood. Mitochon-
dria were isolated as described by Corso and Thomson [21], 
briefly, the placentae were placed in chilled PBS and the 
tissues from the maternal side of the placenta were diced into 
pieces of approximately 1cm
3. The diced tissues were ho-
mogenised in homogenisation buffer containing: 20mM Tris-
HCl, 210mM mannitol, and 70mM sucrose. The homogenate 
was then centrifuged (Beckman J2-21M/E Centrifuge) at 700 
× g for 10 minutes at 4ºC to remove cell debris and nuclei, 
for brevity the pellet from this stage will be referred to as 
nuclei. The supernatant was decanted and stored at 4ºC, and 
the pellet was resuspended twice using the homogenisation 
buffer and centrifuged at 700 × g for 10 minutes at 4ºC. The 
combined supernatants were centrifuged at 9750 × g for 15 
minutes at 4ºC to yield the mitochondrial pellet. The mito-
chondria were washed free of microsomes and cytosol in the 
supernatant three times by re-suspension, using a dounce 
homogenizer, in homogenisation buffer and centrifuged at 
9750 × g for 15 minutes at 4ºC. For brevity the supernatant 
at this stage will be referred to as microsomes. After three 
washes the supernatants were removed and the mitochondria 
pellet was re-suspended in the homogenisation buffer. This 
preparation is referred to as mitochondria.  
Separation of Heavy and Light Mitochondria 
  Isolated mitochondria from human placentae were sepa-
rated into heavy mitochondria characteristic of cytotro-
phoblast mitochondria and light mitochondria characteristic 
of syncytiotrophoblast mitochondria by sequential centrifu-
gation following the method of Martinez and colleagues 
[20]. Briefly, mitochondria were resuspended in an equal 
volume of homogenisation buffer and centrifuged at 4000 × 
g for 15 minutes at 4ºC. The pellet was designated as heavy 
mitochondria. The pellet was removed and the supernatant 
was further centrifuged at 16,000 × g for 15 minutes at 4ºC 
to obtain light mitochondria.  
Fractionation of Mitochondria 
  To produce vesicles of inner membrane, outer membrane 
and vesicles of outer and inner membrane joined by a contact 
site, whole unbroken mitochondria were processed by an 
established swelling and shrinking procedure and sucrose 
gradient separation technique [22-24]. Briefly, mitochondria 
in homogenisation buffer were centrifuged at 9750 × g for 15 
minutes at 4ºC to remove the excess buffer then subjected to 
swelling and shrinking by resuspension and incubation in 
7.5ml of 10mM phosphate buffer at 4ºC for 20 minutes, fol-
lowed by the addition of 3ml of 60% sucrose and further 
incubated at 4ºC for 20 minutes. Mitochondrial membranes 
were further disrupted by sonication using Sonifier B-12 
(Branson Sonic Power Company) three times for 30 seconds 
at level 6 with 30 second intervals in between. Unbroken 
mitochondria were removed by centrifugation (using Beck-
man J2-21M/E Centrifuge) at 9750 × g for 20 minutes at 
4ºC. This process produces vesicles of inner membrane that 
are generally relatively large, smaller vesicles of outer mem-
brane and vesicles of outer membrane joined at a contact site 
to a vesicle of inner membrane and these complexes are 
mainly intermediate in size. 5ml aliquots of suspensions of 
vesicles (with protein concentration of approximately 
5mg/ml) were layered on a 23ml, 24.4%-61.2% continuous 
sucrose density gradient. Sucrose gradients were subjected to 
ultracentrifugation (using Beckman XL-90 Ultracentrifuge) 
at 100,000 × g for 20 hours at 4ºC. The gradient was then 
collected as 20 fractions of 1.4ml each, starting at the bottom 
of the tube. The majority of inner membrane is found at the 
bottom of the tube, the outer membrane is located mainly 
towards the top of the tube and the contact sites are located 
between the inner and outer membrane [22, 23, 16, 24]. The 
positions of outer and inner membrane were checked to be 
the same as previous implementations of this procedure us-
ing enzyme markers [24]. 
Protein Concentration Estimation 
 The  protein  concentration  of samples from each placenta 
was assayed using the Pierce Bicinchoninic acid (BCA) Pro-
tein Assay Kit and Bio-Rad Microplate Manager (Version 
5.0.1) as per manufacturer instructions.  
Sodium Dodecyl Sulphate Polyacrylamide Gel Electro-
phoresis (SDS PAGE) 
  All samples were diluted so as to contain an equal 
amount of protein. Samples containing a total of 20 g of 
protein were loaded onto a 12% SDS gel and run at a voltage 
of 100V using the Biorad Protean III System according to 
the manufacturer until the bromophenol blue dye font 
reached the bottom of the gel (approximately 2 hours). For 
sucrose gradient samples the first 19 fractions were loaded 
leaving one lane free for standard molecular weight markers. 
Protein bands were detected using Coomassie blue stain. 
Where a representative single lane from several repeats is 
shown in a diagram, the lane shown is that of the first sample 
analysed. There was no post result selection of lanes for dia-
grams. 
Western Blotting 
  Proteins were transferred to nitrocellulose membrane 
(100V for 1 hour) using a Mini Trans-Blot system (Bio-Rad 
laboratories) according to manufacturer’s instructions. Com-
plete transference of colour coded molecular weight stan-PKA and AKAP79 in Human Placental Mitochondria  The Open Biochemistry Journal, 2012, Volume 6    25 
dards from the gel to the nitrocellulose membrane was 
checked. The nitrocellulose membrane was blocked with 5% 
skim milk in 1% phosphate-buffered saline (1% PBS) for 1 
hour. Following the blocking of non-specific binding the 
nitrocellulose membrane was incubated with primary anti-
body for 1 hour. The primary antibodies used were PKAα 
Cat (C-20) rabbit polyclonal IgG antibody (Santa Cruz) and 
AKAP79 (H-105) rabbit polyclonal IgG antibody (Santa 
Cruz). The membranes were given 2 quick rinses in phos-
phate-buffered saline containing 0.05% (v/v) Tween-20 
(TPBS), 4 × 5 minutes washes with TPBS, and 30 minutes 
incubation in secondary antibody. The membrane was then 
given 2 quick rinses in TPBS, 4 × 5 minutes washes in 
TPBS, 1 rinse in PBS and then incubated in chemilumines-
cent substrate (Pierce SuperSignal West Pico) as per the 
manufacturer’s instructions. The membranes were then ex-
posed to film (Pierce Cl-Xposure) for various times and were 
analysed using the public domain computer program ImageJ, 
a Java conversion of NIH Image developed at the U.S. Na-
tional Institutes of Health and available on the Internet at 
http://rsb.info.nih.gov/nih-image/).  
Statistical Analysis 
  Results were analysed by paired t-test assuming equal 
variance and a P value of 0.05 or less was considered signifi-
cant. 
RESULTS 
Isolation of Cellular Fractions from Human Placenta 
  Proteins in the, crude homogenate, nuclei, microsomes 
and mitochondria from three different human placentae were 
analysed using SDS PAGE and detected using Coomassie 
blue (Fig. 1). The homogenate, nuclei, microsomes and mi-
tochondria showed protein band patterns, which spanned the 
7-215 kDa molecular weight range. Densitometry analysis of 
the bands displayed in Fig. (1A) showed that the total pla-
centa homogenate and microsomes displayed major peaks at 
65 and 10 kDa that were not present in mitochondrial frac-
tions (Fig. 1B). 
PKAα Cat expression in Human Placental Tissue 
  When Western blots of nuclei, microsomes and mito-
chondria were probed with the PKAα Cat antibody they all 
displayed a major band of immunoreactivity at approxi-
mately 44 kDa (Fig. 2). A minor band was observed at an 
approximately 90 kDa. One sample of each cellular fraction 
from three different placentae was analysed, and similar re-
sults were observed in three different human placentae (Fig. 
2). The intensity of the 44 kDa PKAα Cat band in micro-
some fractions was significantly higher than in mitochondria 
(p = 0.02). On the other hand, there was no significant dif-
ference in the band intensity between nuclei and mitochon-
dria (p = 0.30), and nuclei and microsomes (p = 0.23).  
PKAα Cat expression in Heavy And light Mitochondria 
  To determine the difference in the level of PKAα Cat 
expression in heavy and light placental mitochondria, iso-
lated mitochondria were separated into heavy and light mito-
chondria as described in methods and materials. Each pla-
centa (of a total of 5) yielded one isolate of heavy mitochon-
dria and one isolate of light mitochondria. From each isolate 
(from each placenta) four aliquots were taken for SDS PAGE 
analysis and Western blotting. The process was repeated a 
total of five times, each of these times using a different pla-
centa. 
  The intensities of the PKAα Cat immuno-reactive bands 
at 44 kDa in heavy and light mitochondria were compared 
for isolates from each placenta, (Fig. 3). There was no sig-
   
Fig. (1). SDS PAGE analysis of proteins in homogenate (H), nuclei (N), microsomes (Mic) and mitochondria (Mit) fractions from human 
placenta. Similar results were observed in a total of 3 different placentae. Gels stained with Coomassie are shown in A), densitometry scans 
of the lanes are shown in B) the positions at 65 kDa and 10 kDa are indicated with dotted lines. 26    The Open Biochemistry Journal, 2012, Volume 6  Ma and Thomson 
   
Fig. (2). PKAα Cat expression in nuclei (N), microsomes (Mic) and mitochondria (Mit) from 3 different human placentae, (P1, P2 and P3). 
For each placenta one sample from each fraction was analysed. SDS PAGE, Western blotting and autoradiography results shown in A). A 
major protein band with approximate size of 44 kDa was detected in all fractions by the PKAα Cat antibody. A minor band at approximately 
90 kDa was also present. The relative intensity taken as percentage of the most intense band for each placenta (values represent the mean ± 
S.E.) of the 44 kDa bands shown in A) are plotted in B). An asterisk indicates a significant difference with a p value of less than 0.05.  
 
Fig. (3). Comparison of PKAα Cat expression in heavy (H) and light (L) mitochondria. For each of 5 placentae one preparation of heavy and 
one preparation of light mitochondria was produced. For each preparation of light or heavy mitochondria, three aliquots were taken for SDS 
PAGE and Western blot, the intensities of the three 44 kDa protein bands in each preparation of heavy and light mitochondria from five dif-
ferent human placentae are shown. Values represent the mean ± S.E. of triplicate samples ■ - heavy mitochondria; ■- light mitochondria. An 
asterisk indicates a significant difference with a p value of less than 0.05. 
nificant difference in the band intensity for the 44 kDa PKAα 
Cat immuno-reactive band between the heavy and light mi-
tochondria in four out of five human placentae (p = 0.94 for 
placenta 1, p = 0.96 for placenta 2, p = 0.16 for placenta 3, p 
= 0.40 for placenta 5). There was a significant difference in 
the band intensity for the 44 kDa PKAα Cat immuno-
reactive band between the heavy and light mitochondria in 
human placenta 4 (p = 0.02).  
AKAP79 Expression in Human Placental Tissue 
  Western blots of nuclei, microsomes and mitochondria 
all displayed a major band of AKAP79 immunoreactivity at 
the approximately 80 kDa region using AKAP79 antibody 
(Fig. 4). The intensity of this protein band detected in nuclei, 
microsomes and mitochondria from three different human 
placentae are shown in Fig. (4B). There was no significant 
difference in the band intensity between nuclei, microsomes 
and mitochondria (nuclei and microsomes: p = 0.18; nuclei 
and mitochondria: p = 0.89; microsomes and mitochondria: p 
= 0.09) (Fig. 4B).  
AKAP79 Expression in Heavy and Light Placental Mito-
chondria 
  To determine the difference in the level of AKAP79 ex-
pression in heavy and light placental mitochondria, isolated 
mitochondria were separated into heavy and light mitochon-
dria as described in methods and materials. Each placenta (of 
a total of 5) yielded one isolate of heavy mitochondria and 
one isolate of light mitochondria. From each isolate (from 
each placenta) four aliquots were taken for SDS PAGE 
analysis and Western blotting. The process was repeated a 
total of five times, each of these times using a different pla-
centa. The AKAP79 immuno-reactive band was present in 
both heavy and light mitochondria in all placentae (Fig. 5). 
The band intensity of the AKAP79 band was not signifi-
cantly different as compared between the heavy and light 
placental mitochondria in any of the human placenta (p = PKA and AKAP79 in Human Placental Mitochondria  The Open Biochemistry Journal, 2012, Volume 6    27 
   
Fig. (4). AKAP79 immunoreactivity in nuclei (N), microsomes (Mic) and mitochondria (Mit) from 3 different human placentae, (HP 1, 2 and 
3). SDS PAGE, Western blotting and autoradiography results shown in a). A protein band of approximate size 80 kDa was detected in all 
fractions by the AKAP79 antibody (A). The relative intensity taken as percentage of the most intense band for each placenta (values repre-
sent the mean ± S.E.) of the 80 kDa bands shown in A) are plotted in B)  
 
Fig. (5). Comparison of the AKAP79 expression in the heavy (H) and light (L) mitochondria. For each of 5 placentae one preparation of 
heavy and one preparation of light mitochondria was produced. For each preparation of light or heavy mitochondria, three aliquots were 
taken for SDS PAGE and Western blot. The intensities of the AKAP79 immuno-reactive protein bands in each preparation of heavy and light 
mitochondria from five different human placentae are shown. Values represent the mean ± S.E. of triplicate samples ■ - heavy mitochondria; 
■- light mitochondria. 
0.81 for placenta 1, p = 0.79 for placenta 2, p = 0.21 for pla-
centa 3, p = 0.73 for placenta 4, p = 0.37 for placenta 5).  
PKAα Cat Immunoreactivity in Human Placental Submi-
tochondrial Fractions 
  When submitochondrial fractions were separated on su-
crose gradients and analysed using SDS-PAGE and Western 
blot, PKAα Cat immuno-rearctivity peaked at fraction 17 in 
the outer membrane region of the gradient (Fig. 6).  
AKAP79 Cat Expression in Human Placental   
Submitochondrial Fractions 
  When submitochondrial fractions were separated on su-
crose gradients and analysed using SDS-PAGE and Western 
blot, AKAP79 immuno-reactivity peaked at fraction 12 in 
the contact site region of the gradient (Fig. 7).  
DISCUSSION 
  The method used in this study to fractionate cellular 
components has been shown to produce mitochondria free of 
any significant contamination from microsomes using the ras 
protein as an indicator, ras is present in the microsome frac-
tion but is undetectable in the mitochondria fraction [25]. In 
the present study we again checked the purity of the mito-
chondrial fraction using the 65 and 10 kDa proteins that are 
present in the microsome and homogenate fractions but ab-
sent from the mitochondria fraction (Fig. 1).  
  Prior to this study PKA enzyme activity has been shown 
to be present in human placental mitochondria [21] but 
whether this bioactivity was exerted by a version of PKA 
that contained an α catalytic subunit was not known. Indeed 
there has been no prior study that has shown what PKA sub-
units are present in any cellular location in human placenta. 
In this study the presence of PKACat positive bands of 
immunoreactivity in all three cellular subfractions studied 
(Fig. 2A) indicates that PKACat is ubiquitous in the hu-
man placental cells and that levels of PKACat in the mito-
chondria are of similar concentrations to that found in the 
nuclei (Fig. 2B).  
  The molecular weight estimation by SDS PAGE of ap-
proximately 44 kDa for PKACat is the same reported by 
the antibody manufacturer when detecting PKACat in 
mouse brain extract (http://datasheets.scbt.com/sc-903.pdf) 28    The Open Biochemistry Journal, 2012, Volume 6  Ma and Thomson 
 
Fig. (6). PKAα Cat expression in the human placental mitochondrial fractions. PKAα Cat expression was detected using SDS-PAGE, West-
ern blotting and autoradiography (Exposure time = 1 minute). The PKAα Cat immuno-reactive bands are shown in A), the intensities of the 
44 kDa PKAα Cat bands are shown in B). The experi-ment was repeated for a total of three different placentae with similar results. 
 
Fig. (7). AKAP79 immunoreactivity in the human placental mitochondria fractions. AKAP79 immunoreactivity was detected using SDS-
PAGE, Western blotting and autoradiography (Exposure time = 1 minute). The AKAP79 immuno-reactive bands are shown in A) the inten-
sity of the AKAP79 bands are shown in B). The experiment was repeated for a total of three different placentae with similar results. 
and similar to the estimated molecular weight of PKACat 
previously found in the cytoplasm of human myometrium 
(approximately 42 kDa) [8]. SDS PAGE has an accuracy in 
molecular weight determination of up to approximately +/- 
10% [26]. Interestingly, an additional minor PKACat band 
at 90 kDa was detected by the PKAα Cat antibody in mito-
chondria as well as nuclei and microsomes (Fig. 2). The mi-
nor 90 kDa band may indicate some aggregation of 
PKACat or the presence of a larger weight precursor pro-
tein.  
  Cytotrophoblast mitochondria are heavier than syncyti-
otrophoblast mitochondria [20] and the finding that the level 
of PKAα Cat immunoreactivity was not significantly differ-
ent in light mitochondria as compared to heavy mitochondria 
in four out of five placentae tested (Fig. 3) suggests that 
syncytiotrophoblast mitochondria do not need significantly 
more PKA than cytotrophoblast mitochondria for physio-
logical uses of PKA in the organelle. Previous studies using 
phosphotyrosine antibodies have demonstrated that while 
some phosphotyrosine proteins are evenly distributed be-
tween heavy and light mitochondria, the concentrations of 
two phosphoproteins of 20 and 16 kDa molecular weight was 
significantly higher in heavy mitochondria. Additionally, the 
amount of porin, the protein that makes up the voltage de-
pendent anion channel in mitochondria is significantly higher 
in heavy mitochondria (Ma and Thomson unpublished re-
sults). It will be interesting to determine in future studies PKA and AKAP79 in Human Placental Mitochondria  The Open Biochemistry Journal, 2012, Volume 6    29 
what physiological roles PKA is playing in the mitochondria 
of both syncytiotrophoblast and cytotrophoblast. 
  For PKA to be involved in physiological processes in the 
mitochondria of human placenta it would be expected that an 
AKAP would be present in the organelle to fasten the protein 
in the organelle [2]. Figs (4, 5) and (7) indicate that human 
placental mitochondria contain at least one AKAP, AKAP79 
at concentrations that are similar to those found in the nuclei 
and microsome fractions (Fig. 4). This AKAP79 displays a 
similar migration distance in SDS PAGE compared to 
AKAP79 in other cells such as neuroblastoma and myoblast 
cell lines [27]. Both cytotrophoblast and syncytiotrophoblast 
mitochondria appear to contain this AKAP at similar concen-
trations and future studies may reveal the role played by 
AKAP79 in both types of mitochondria. Fig. (5) indicates 
that both heavy and light mitochondria contain similar 
amounts of AKAP79 immunoreactivity and it will be impor-
tant in future investigations to determine whether AKAP79 
is binding PKA subunits with active enzyme activity in both 
heavy and light mitochondria of human placenta. 
  The pattern of PKAα Cat immunoreactivity in sucrose 
gradient separations of submitochondrial fractions suggests 
that PKAα Cat is located predominantly in the outer mem-
brane (Fig. 6). AKAP79 on the other hand appears to be lo-
cated predominantly in contact site vesicles (Fig. 7) and so it 
appears that the majority of AKAP79 is not responsible for 
anchoring the majority of PKAα Cat in these mitochondria. 
It is possible that another species of AKAP may be anchor-
ing substantial quantities of the PKA in placental mitochon-
dria. Submitochondrial fractionation on sucrose gradients are 
useful to show where the majority of a protein is in the mito-
chondrion but because of the heterogeneity in size of submi-
tochondrial particles the technique cannot fully purify inner 
membrane from outer membrane and cannot quantify the 
relative amounts of a protein in different mitochondrial loca-
tions (see Thomson for review) [16]. Therefore the possibil-
ity remains that smaller amounts of AKAP79 in the outer 
membrane may contribute to the anchoring of PKA in this 
region.  
  Indeed, there is a paucity of information on the protein 
kinase and AKAP species that are present in the human pla-
centa and it will be important in future studies to determine 
what combinations and configurations of kinase subunits and 
anchors are present in the cells and sub-cellular locations of 
the organ. Future experiments using electron microscopy and 
immuno-gold labelling [28] may help to show what AKAP 
species are co-localised with PKA in the mitochondria. In 
some steroidogenic tissues phosphorylation of the steroido-
genic acute regulatory protein (StAR) in or close to the mito-
chondria by PKA is thought to accelerate cholesterol trans-
port to the inner membrane for conversion to pregnenolone 
[29-32] and AKAP121 appears to facilitate steroidogenesis 
in the mouse leydig cell line MA-10 [33].  
CONCLUSION 
  This study has indicated that PKAα Cat and AKAP79 are 
present in the mitochondria of both cytotrophoblast and 
syncytiotrophoblast. PKAα Cat it is located mainly in the 
outer membrane whereas AKAP79 is located predominantly 
in the contact sites. Future experiments are necessary to es-
tablish the physiological roles of PKAα Cat and AKAP79 in 
the mitochondria of human placenta.  
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ABBREVIATIONS 
AKAP79  =  A Kinase Anchoring Protein of approxi-
mate molecular weight 79 kDa 
BCA =  Bicinchoninic  acid 
Cat   =  Catalytic 
MP20  =  Mitochondrial protein of 20 kDa 
OCT  =  Optimal cutting temperature 
PBS =  Phosphate  buffered  saline 
PKA Cat  =  Protein Kinase A Subunit  Catalytic 
Reg =  Regulatory 
StAR  =  Steroidogenic acute regulatory protein 
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